<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610774</url>
  </required_header>
  <id_info>
    <org_study_id>RC 23.9.2022</org_study_id>
    <nct_id>NCT05610774</nct_id>
  </id_info>
  <brief_title>Optic Nerve Sheath Diameter Use in Pre-Eclamptic Parturient Receiving Magnesium Sulfate</brief_title>
  <official_title>Using Optic Nerve Sheath Diameter to Monitor Intracranial Tension in Pre-Eclamptic Parturient Receiving Magnesium Sulfate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the effect of MgSO4 on ONSD in severely pre-eclamptic parturients has been underestimated.&#xD;
      Though this study aims to evaluate the effect of magnesium sulphate on raised ICP in severely&#xD;
      pre-eclamptic parturients using ocular ultrasonography to determine ONSD as a measure of ICP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnesium Sulphate (MgS04) has been used for decades in obstetrics for the prevention and&#xD;
      treatment of seizures in pre-eclamptic and eclamptic parturients. However, the effect of&#xD;
      MgSO4 treatment on raised intracranial pressure (ICP) is still unclear.&#xD;
&#xD;
      Clinical signs of raised ICP are not specific and often difficult to interpret, especially&#xD;
      during pregnancy and pre-eclampsia. Though the use of invasive devices is considered a gold&#xD;
      standard in the measurement of ICP, Ocular sonography is a promising bedside tool, which&#xD;
      serves as a noninvasive, readily available, and cost-effective means for indirectly measuring&#xD;
      ICP.&#xD;
&#xD;
      Bedside ultrasound can be used as a point-of-care tool for rapidly measuring the optic nerve&#xD;
      sheath diameter (ONSD), which is a validated indirect means for measuring ICP. An increase in&#xD;
      ICP reflects as a raised ONSD since the optic nerve is surrounded by Dural sheath and&#xD;
      cerebrospinal fluid (CSF) containing subarachnoid space, which is distensible in the&#xD;
      retrobulbar segment, particularly when CSF pressures rise.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 28, 2022</start_date>
  <completion_date type="Anticipated">May 10, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optic nerve sheath diameter (ONSD) changes following MgSO4 treatment</measure>
    <time_frame>Baseline (before starting MgSO4 therapy) then at 4, 12 and 24 hours after MgSO4 apply</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of raised ICP in severe pre-eclampsia</measure>
    <time_frame>Baseline (before starting MgSO4 therapy)</time_frame>
    <description>ONSD &gt;5.0 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of ONSD with serum magnesium levels</measure>
    <time_frame>at 4, 12 and 24 hours after MgSO4 therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of ONSD with Mean Arterial Presuure</measure>
    <time_frame>at 4, 12 and 24 hours after MgSO4 therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial pressure (MAP) changes following MgSo4 therapy.</measure>
    <time_frame>Baseline (before starting MgSO4 therapy) then at 4, 12 and 24 hours after MgSO4 therapy</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Preeclampsia Severe</condition>
  <condition>Optic Nerve Sheath Diameter</condition>
  <eligibility>
    <study_pop>
      <textblock>
        preeclampsia with severe features will be defined using the American College of&#xD;
        Obstetricians and Gynecologist Task Force on Hypertension in Pregnancy recommendation [16];&#xD;
        as raised blood pressure (BP) &gt;160/110 mmHg, proteinuria more than 5 g/day, oliguria (&lt;500&#xD;
        mL/day), elevated serum creatinine, intrauterine growth retardation, pulmonary edema,&#xD;
        central nervous system manifestations (headache, visual disturbances, seizures, and&#xD;
        stroke), hepatic tenderness, or the HELLP syndrome.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged18 to 40 years with&#xD;
&#xD;
          -  singleton pregnancy ≥ 28weeks of gestation,&#xD;
&#xD;
          -  admitted with diagnosis of severe pre-eclampsia and scheduled to receive Magnesium&#xD;
             Sulphate therapy before delivery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of ocular wound&#xD;
&#xD;
          -  Prior ocular surgery&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Chronic hypertension&#xD;
&#xD;
          -  Hyperthyroidism&#xD;
&#xD;
          -  Presence of pre-existing chronic lung and/or cardiac diseases&#xD;
&#xD;
          -  Presence of pre-existing chronic renal and/or hepatic diseases&#xD;
&#xD;
          -  Presence of any chronic diseases of central nervous system.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samar R Amin, MD</last_name>
    <phone>01287793991</phone>
    <email>samar.rafik@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Enas W Mahdy</last_name>
    <phone>01029286117</phone>
    <email>enaswageh@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samar Rafik Amin</name>
      <address>
        <city>Banhā</city>
        <state>Qalubia</state>
        <zip>13511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samar R. Amin, lecturer</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 1, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>November 8, 2022</last_update_submitted>
  <last_update_submitted_qc>November 8, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Samar Rafik Mohamed Amin</investigator_full_name>
    <investigator_title>lecturer of anesthesia and surgical ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

